Cargando…

Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands

Here we show that keratinocytes in psoriatic lesional skin express increased Toll-like receptor (TLR) 9 that similarly localizes with elevated expression of the cathelicidin antimicrobial peptide LL-37. In culture, normal human keratinocytes exposed to LL-37 increased TLR9 expression. Furthermore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Morizane, Shin, Yamasaki, Kenshi, Mühleisen, Beda, Kotol, Paul F., Murakami, Masamoto, Aoyama, Yumi, Iwatsuki, Keiji, Hata, Tissa, Gallo, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220926/
https://www.ncbi.nlm.nih.gov/pubmed/21850017
http://dx.doi.org/10.1038/jid.2011.259
_version_ 1782217018822361088
author Morizane, Shin
Yamasaki, Kenshi
Mühleisen, Beda
Kotol, Paul F.
Murakami, Masamoto
Aoyama, Yumi
Iwatsuki, Keiji
Hata, Tissa
Gallo, Richard L.
author_facet Morizane, Shin
Yamasaki, Kenshi
Mühleisen, Beda
Kotol, Paul F.
Murakami, Masamoto
Aoyama, Yumi
Iwatsuki, Keiji
Hata, Tissa
Gallo, Richard L.
author_sort Morizane, Shin
collection PubMed
description Here we show that keratinocytes in psoriatic lesional skin express increased Toll-like receptor (TLR) 9 that similarly localizes with elevated expression of the cathelicidin antimicrobial peptide LL-37. In culture, normal human keratinocytes exposed to LL-37 increased TLR9 expression. Furthermore, when keratinocytes were exposed to LL-37 and subsequently treated with TLR9 ligands such as CpG or genomic DNA, keratinocytes greatly increased production of type I interferons. This response mimicked observations in the epidermis of psoriatic lesional skin as keratinocytes in psoriatic lesions produce greater amounts of interferon-β than normal skin lacking LL-37. The mechanism for induction of type I interferons in keratinocytes was dependent on TLR9 expression but not on a DNA-LL-37 complex. These findings suggest that keratinocytes recognize and respond to DNA and can actively participate in contributing to the immunological environment that characterizes psoriasis.
format Online
Article
Text
id pubmed-3220926
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-32209262012-07-01 Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands Morizane, Shin Yamasaki, Kenshi Mühleisen, Beda Kotol, Paul F. Murakami, Masamoto Aoyama, Yumi Iwatsuki, Keiji Hata, Tissa Gallo, Richard L. J Invest Dermatol Article Here we show that keratinocytes in psoriatic lesional skin express increased Toll-like receptor (TLR) 9 that similarly localizes with elevated expression of the cathelicidin antimicrobial peptide LL-37. In culture, normal human keratinocytes exposed to LL-37 increased TLR9 expression. Furthermore, when keratinocytes were exposed to LL-37 and subsequently treated with TLR9 ligands such as CpG or genomic DNA, keratinocytes greatly increased production of type I interferons. This response mimicked observations in the epidermis of psoriatic lesional skin as keratinocytes in psoriatic lesions produce greater amounts of interferon-β than normal skin lacking LL-37. The mechanism for induction of type I interferons in keratinocytes was dependent on TLR9 expression but not on a DNA-LL-37 complex. These findings suggest that keratinocytes recognize and respond to DNA and can actively participate in contributing to the immunological environment that characterizes psoriasis. 2011-08-18 2012-01 /pmc/articles/PMC3220926/ /pubmed/21850017 http://dx.doi.org/10.1038/jid.2011.259 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Morizane, Shin
Yamasaki, Kenshi
Mühleisen, Beda
Kotol, Paul F.
Murakami, Masamoto
Aoyama, Yumi
Iwatsuki, Keiji
Hata, Tissa
Gallo, Richard L.
Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title_full Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title_fullStr Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title_full_unstemmed Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title_short Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
title_sort cathelicidin antimicrobial peptide ll-37 in psoriasis enables keratinocyte reactivity against tlr9 ligands
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220926/
https://www.ncbi.nlm.nih.gov/pubmed/21850017
http://dx.doi.org/10.1038/jid.2011.259
work_keys_str_mv AT morizaneshin cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT yamasakikenshi cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT muhleisenbeda cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT kotolpaulf cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT murakamimasamoto cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT aoyamayumi cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT iwatsukikeiji cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT hatatissa cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands
AT gallorichardl cathelicidinantimicrobialpeptidell37inpsoriasisenableskeratinocytereactivityagainsttlr9ligands